|
| Linking miR-138 and USP10-P53 signaling |
|
https://doi.org/10.18632/oncotarget.27260
Ri Cui
|
| 6541-6542 |
|
| Targeting phosphatases in cancer: suppression of many versus the ablation of one |
|
https://doi.org/10.18632/oncotarget.27201
Brandon M. D’Arcy, Aishwarya Prakash, Richard E. Honkanen
|
| 6543-6545 |
|
| Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment |
|
https://doi.org/10.18632/oncotarget.27283
María José Godoy-Calderón, Eglys González-Marcano, Jeismar Carballo, Ana Federica Convit
|
| 6546-6560 |
|
| The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44 |
|
https://doi.org/10.18632/oncotarget.27302
Chunmei Zhao, Benjamin J. Thompson, Kelly Chen, Feng Gao, Barbara Blouw, Mathieu Marella, Susan Zimmerman, Trevor Kimbler, Sheryl Garrovillo, Jesse Bahn, Lei Huang, Zhongdong Huang, H. Michael Shepard, Sanna Rosengren, Christopher D. Thanos, Daniel C. Maneval
|
| 6561-6576 |
|
| High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target |
|
https://doi.org/10.18632/oncotarget.27312
Guilhem Bousquet, Jean-Paul Feugeas, Yuchen Gu, Christophe Leboeuf, Morad El Bouchtaoui, He Lu, Marc Espié, Anne Janin, Melanie Di Benedetto
|
| 6577-6588 |
|
| The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer |
|
https://doi.org/10.18632/oncotarget.27284
Ana Emília Goulart Lemos, Aline da Rocha Matos, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba
|
| 6589-6603 |
|
| Tumor mutational burden in lung cancer: a systematic literature review |
|
https://doi.org/10.18632/oncotarget.27287
Connor Willis, Michelle Fiander, Dao Tran, Beata Korytowsky, John-Michael Thomas, Florencio Calderon, Teresa M. Zyczynski, Diana Brixner, David D. Stenehjem
|
| 6604-6622 |
|
| The multifaceted anti-cancer effects of BRAF-inhibitors |
|
https://doi.org/10.18632/oncotarget.27304
Laura Croce, Francesca Coperchini, Flavia Magri, Luca Chiovato, Mario Rotondi
|
| 6623-6640 |
|
| Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.27310
Xia Li, Xiufeng Yin, Huafeng Wang, Jiansong Huang, Mengxia Yu, Zhixin Ma, Chenying Li, Yile Zhou, Xiao Yan, ShuJuan Huang, Jie Jin
|
| 6641-6642 |
|
| Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells |
|
https://doi.org/10.18632/oncotarget.27314
Ana Fernandez-Carrascal, Manuel Garcia-Algar, Moritz Nazarenus, Alicia Torres-Nuñez, Luca Guerrini, Neus Feliu, Wolfgang J. Parak, Eduardo Garcia-Rico, Ramon A. Alvarez-Puebla
|
| 6643-6643 |
|
| Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype |
|
https://doi.org/10.18632/oncotarget.27315
Xiaoqun Dong, Qiushi Lin, Arihiro Aihara, Yu Li, Chiung-Kuei Huang, Waihong Chung, Qi Tang, Xuesong Chen, Rolf Carlson, Christina Nadolny, Gregory Gabriel, Mark Olsen, Jack R. Wands
|
| 6644-6646 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
